In8bio, Inc. · NASDAQ:INAB
In8bio, Inc. shareholders
As of Jun 30, 2026, 20 institutions reported holding In8bio, Inc., 38.4% of its shares. Largest: Alyeska Investment Group, L.P., Franklin Templeton and 683 Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of In8bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 944K | 9.6% | no change | Aug 14, 2026 |
| Franklin Templeton | 915K | 9.3% | no change | Aug 13, 2026 |
| 683 Capital Management, LLC | 725K | 7.4% | no change | Aug 14, 2026 |
| Stonepine Capital Management, LLC | 695K | 7.1% | +31,875 | Aug 17, 2026 |
| Vanguard | 132K | 1.3% | no change | Aug 13, 2026 |
| BIOS Capital Management, LP | 80,957 | 0.82% | −86,848 | Aug 14, 2026 |
| Geode Capital | 72,550 | 0.74% | −13,689 | Aug 12, 2026 |
| Citadel | 63,055 | 0.64% | new | Aug 14, 2026 |
| Oppenheimer & Co Inc | 63,042 | 0.64% | +39,009 | Aug 3, 2026 |
| Captrust Financial Advisors | 33,295 | 0.34% | no change | Aug 13, 2026 |